Thrombosis and anticoagulation in liver disease. (Q37101518)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18318436%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

review article

1 reference

title

Thrombosis and anticoagulation in liver disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18318436%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18318436%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

author name string

Dominique Charles Valla

series ordinal

1

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 April 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18318436%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18318436%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

volume

47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18318436%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

page(s)

1384-1393

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18318436%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18318436%20AND%20SRC:MED&resulttype=core&format=json

Venous thrombosis: the role of genes, environment, and behavior

3 January 2020

cites work

1 reference

Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies

21 January 2018

1 reference

The diagnosis and management of the Budd-Chiari syndrome: consensus and controversies.

21 January 2018

1 reference

The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis

21 January 2018

1 reference

Association between thrombotic risk factors and extent of fibrosis in patients with non-alcoholic fatty liver diseases

21 January 2018

1 reference

Effects of heparin on liver fibrosis in patients with chronic hepatitis B.

21 January 2018

1 reference

Adams-Oliver syndrome and hepatoportal sclerosis: Occasional association or common mechanism?

21 January 2018

1 reference

Deficiency of natural anticoagulant proteins C, S, and antithrombin in portal vein thrombosis: a secondary phenomenon?

21 January 2018

1 reference

7 January 2021

Relevance of the criteria commonly used to diagnose myeloproliferative disorder in patients with splanchnic vein thrombosis

1 reference

7 January 2021

Histological and molecular classification of chronic myeloproliferative disorders in the age of JAK2: persistence of old questions despite new answers

1 reference

7 January 2021

Anticardiolipin antibodies in patients with liver disease

1 reference

7 January 2021

Ischemic cholangiopathy

1 reference

7 January 2021

Nonmalignant portal vein thrombosis in adults

1 reference

7 January 2021

Risk factors for thrombophilia in extrahepatic portal vein obstruction

1 reference

7 January 2021

Cause of portal or hepatic venous thrombosis in adults: The role of multiple concurrent factors

1 reference

7 January 2021

Prognostic factors in noncirrhotic patients with splanchnic vein thromboses

1 reference

7 January 2021

Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis

1 reference

7 January 2021

Gain-of-function gene mutations and venous thromboembolism: distinct roles in different clinical settings

1 reference

7 January 2021

JAK2V617F Mutation in Unexplained Loss of First Pregnancy

1 reference

7 January 2021

Temporal relationship of peripheral vasodilatation, plasma volume expansion and the hyperdynamic circulatory state in portal-hypertensive rats.

1 reference

7 January 2021

Clinical practice. Treatment of deep-vein thrombosis

1 reference

7 January 2021

Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension

1 reference

7 January 2021

Transcatheter thrombolytic therapy for acute mesenteric and portal vein thrombosis

1 reference

7 January 2021

Current outcome of portal vein thrombosis in adults: Risk and benefit of anticoagulant therapy

1 reference

7 January 2021

Bleeding esophagogastric varices from extrahepatic portal hypertension: 40 years' experience with portal-systemic shunt

1 reference

7 January 2021

Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation

1 reference

7 January 2021

Correction of extrahepatic portal vein thrombosis by the mesenteric to left portal vein bypass

1 reference

7 January 2021

Chronic oral anticoagulant therapy for extrahepatic visceral thrombosis is safe.

1 reference

7 January 2021

Histopathology of the liver in non-cirrhotic portal hypertension of unknown aetiology

1 reference

7 January 2021

Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients

1 reference

7 January 2021

Vascular involvement of the liver in Turner's syndrome

1 reference

7 January 2021

Molecular basis for arsenic-induced alteration in nitric oxide production and oxidative stress: implication of endothelial dysfunction

1 reference

7 January 2021

Liver failure and need for liver transplantation in patients with advanced hepatoportal sclerosis

1 reference

7 January 2021

Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome

1 reference

7 January 2021

Hepatic vascular disease and portal hypertension in polycythemia vera and agnogenic myeloid metaplasia: a clinicopathological study of 145 patients examined at autopsy

1 reference

7 January 2021

Endemicity and clinical picture of liver disease due to obstruction of the hepatic portion of the inferior vena cava in Nepal

1 reference

7 January 2021

Risk of hepatic vein thrombosis in relation to recent use of oral contraceptives. A case-control study

1 reference

7 January 2021

Hepatic outflow obstruction (Budd-Chiari syndrome). Experience with 177 patients and a review of the literature

1 reference

7 January 2021

Factor V Leiden related Budd-Chiari syndrome

1 reference

7 January 2021

Arterial and portal circulation and parenchymal changes in Budd-Chiari syndrome: A study in 17 explanted livers

1 reference

7 January 2021

Outcome of Budd-Chiari syndrome: A multivariate analysis of factors related to survival including surgical portosystemic shunting

1 reference

7 January 2021

Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome.

1 reference

7 January 2021

Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome

1 reference

7 January 2021

Long-term effect of stent placement in 115 patients with Budd-Chiari syndrome

1 reference

7 January 2021

Liver transplantation for Budd-Chiari syndrome: A European study on 248 patients from 51 centres.

1 reference

7 January 2021

Budd-Chiari syndrome: a review by an expert panel.

1 reference

7 January 2021

Favourable medium term outcome following hepatic vein recanalisation and/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome.

1 reference

7 January 2021

Incidence of portal vein thrombosis in liver cirrhosis. An angiographic study in 708 patients

1 reference

7 January 2021

Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation

1 reference

7 January 2021

Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis.

1 reference

7 January 2021

Pathology of the liver in Budd-Chiari syndrome: portal vein thrombosis and the histogenesis of veno-centric cirrhosis, veno-portal cirrhosis, and large regenerative nodules

1 reference

7 January 2021

Accumulation and cellular localization of fibrinogen/fibrin during short-term and long-term rat liver injury

1 reference

7 January 2021

Thrombin inhibits migration of human hepatic myofibroblasts

1 reference

7 January 2021

PAR1 antagonism protects against experimental liver fibrosis. Role of proteinase receptors in stellate cell activation

1 reference

7 January 2021

Low molecular weight heparin prevents hepatic fibrogenesis caused by carbon tetrachloride in the rat.

1 reference

7 January 2021

Expression of the thrombin receptor in human liver: Up-regulation during acute and chronic injury

1 reference

7 January 2021

Genetic and acquired thrombotic factors in chronic hepatitis C.

1 reference

7 January 2021

Factor V Leiden as a risk factor for cirrhosis in chronic hepatitis C.

1 reference

7 January 2021

The JAK2 V617F mutation frequently occurs in patients with portal and mesenteric venous thrombosis

1 reference

7 January 2021